PROCEPT BioRobotics Corporation
$25.73
▼
-0.95%
2026-04-21 08:56:00
www.procept-biorobotics.com
NGM: PRCT
Explore PROCEPT BioRobotics Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.45 B
Current Price
$25.73
52W High / Low
$66.85 / $19.35
Stock P/E
—
Book Value
$6.5
Dividend Yield
—
ROCE
-23.48%
ROE
-24.89%
Face Value
—
EPS
$-1.72
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
888
Beta
0.93
Debt / Equity
21.45
Current Ratio
6.84
Quick Ratio
5.77
Forward P/E
-26.27
Price / Sales
4.25
Enterprise Value
$1.1 B
EV / EBITDA
-11.29
EV / Revenue
3.57
Rating
Buy
Target Price
$30.44
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Quantum-Si incorporated | $1.01 | — | $231.51 M | — | -43.74% | -46.52% | $3.1 / $0.69 | $1.02 |
| 2. | Integra LifeSciences Holdings Corporation | $11.16 | — | $875.54 M | — | 0.57% | -39.9% | $17.54 / $8.7 | $13.4 |
| 3. | Enovis Corporation | $26.27 | — | $1.52 B | — | -0.58% | -58.27% | $37.85 / $21 | $26.05 |
| 4. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 5. | Outset Medical, Inc. | $4.61 | — | $84.32 M | — | -29.4% | -1.06% | $21.98 / $3 | $6.99 |
| 6. | UFP Technologies, Inc. | $201.08 | 22.53 | $1.54 B | — | 16.02% | 17.82% | $274.93 / $182.87 | $54.95 |
| 7. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 76.38 M | 83.33 M | 79.18 M | 69.16 M | 68.24 M | — |
| Operating Profit | -31.04 M | -23.19 M | -22.19 M | -27.44 M | -19.71 M | — |
| Net Profit | -29.84 M | -21.41 M | -19.58 M | -24.74 M | -18.86 M | — |
| EPS in Rs | -0.53 | -0.38 | -0.35 | -0.44 | -0.33 | -0.4 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 308.05 M | 224.5 M | 136.19 M | 75.01 M |
| Operating Profit | -103.86 M | -96.61 M | -109.17 M | -80.72 M |
| Net Profit | -95.57 M | -91.41 M | -105.9 M | -87.15 M |
| EPS in Rs | -1.69 | -1.62 | -1.88 | -1.55 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 508.08 M | 534.02 M | 404.72 M | 309.33 M |
| Total Liabilities | 142.21 M | 131.8 M | 123.97 M | 112.26 M |
| Equity | 365.87 M | 402.22 M | 280.75 M | 197.07 M |
| Current Assets | 450.38 M | 481.84 M | 350.57 M | 272.63 M |
| Current Liabilities | 65.8 M | 53.13 M | 45.93 M | 35.29 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -48.98 M | -99.21 M | -108 M | -80.38 M |
| Investing CF | -9.36 M | -4.41 M | -25.21 M | -2.65 M |
| Financing CF | 11.19 M | 180.12 M | 167.79 M | 3.61 M |
| Free CF | -58.34 M | -103.62 M | -133.21 M | -83.03 M |
| Capex | -9.36 M | -4.41 M | -25.21 M | -2.65 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 64.84% | 81.55% | — | — |
| Earnings Growth % | 13.68% | -21.51% | — | — |
| Profit Margin % | -40.72% | -77.76% | -116.18% | — |
| Operating Margin % | -43.04% | -80.16% | -107.61% | — |
| Gross Margin % | 61.07% | 52.17% | 49.44% | — |
| EBITDA Margin % | -36.36% | -71.97% | -105.49% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.